Olympia Financial Group Inc. (TSE:OLY – Get Free Report) Director Anthony Lanzl sold 200 shares of Olympia Financial Group stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of C$107.50, for a total value of C$21,500.00.
Anthony Lanzl also recently made the following trade(s):
- On Wednesday, January 15th, Anthony Lanzl sold 150 shares of Olympia Financial Group stock. The stock was sold at an average price of C$107.25, for a total transaction of C$16,087.50.
Olympia Financial Group Stock Performance
Shares of OLY traded down C$0.21 during midday trading on Monday, hitting C$108.25. 3,273 shares of the stock traded hands, compared to its average volume of 1,845. The company has a debt-to-equity ratio of 11.29, a quick ratio of 1.59 and a current ratio of 2.56. The business’s 50 day moving average price is C$106.27 and its two-hundred day moving average price is C$102.44. The firm has a market capitalization of C$260.88 million, a PE ratio of 11.42 and a beta of 0.27. Olympia Financial Group Inc. has a 1-year low of C$89.90 and a 1-year high of C$122.35.
Olympia Financial Group Announces Dividend
Wall Street Analyst Weigh In
Separately, Fundamental Research set a C$135.19 target price on Olympia Financial Group and gave the stock a “buy” rating in a research report on Tuesday, November 26th.
View Our Latest Stock Analysis on Olympia Financial Group
About Olympia Financial Group
Olympia Financial Group Inc, through its subsidiary, Olympia Trust Company, operates as a non-deposit taking trust company in Canada. The company operates through Investment Account Services, Currency and Global Payments, Private Health Services Plan, Exempt Edge, and Corporate and Shareholder Services divisions.
See Also
- Five stocks we like better than Olympia Financial Group
- Investing in Travel Stocks Benefits
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Apple Comes Out From Behind to Emerge as An AI-Services Leader
- How Investors Can Find the Best Cheap Dividend Stocks
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
Receive News & Ratings for Olympia Financial Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympia Financial Group and related companies with MarketBeat.com's FREE daily email newsletter.